We are live on
!
Find out more
EUCRU
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
EUCRU
Delisted
EUCRU was delisted on the 26th of April, 2023.
4 hedge funds and large institutions have $6.72M invested in Eucrates Biomedical Acquisition Corp. Unit in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
3% more capital invested
Capital invested by funds: $6.51M → $6.72M (+$216K)
33% less funds holding
Funds holding: 6 → 4 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Holders
4
Holders Change
-2
Holders Change %
-33.33%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
CS
Clear Street
New York
|
+$1.01K |
Top Sellers
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$26.3K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$3.94K |